BRCA2 and ovarian cancer: Diverse defects in HR DNA repair genes, such as germline mutations in BRCA1, BRCA2, and PALB2, somatic mutations in BRCA1 and BRCA2, and promoter methylation of BRCA1, have been reported in breast and ovarian cancers (35, 36).